New treatment for bipolar disorder launched.
- Published in:
- Expert Review of Pharmacoeconomics & Outcomes Research, 2009, v. 9, n. 2, p. 112
- Publication type:
- Article
Works matching DE "ASTRAZENECA Pharmaceuticals LP"
Results: 13
1
2
Chronology: The European Union in 2005.
- Published in:
- Journal of Common Market Studies, 2006, v. 44, n. s1, p. 231, doi. 10.1111/j.1468-5965.2006.00655.x
- By:
- Publication type:
- Article
3
PRODUCT UPDATE.
- Published in:
- Oncology Nursing Forum, 2005, v. 32, n. 6, p. 1217, doi. 10.1188/05.ONF.1217-1218
- Publication type:
- Article
4
Exhibit Hall Floorplan.
- Published in:
- Oncology Nursing Forum, 2004, v. 31, n. 2, p. 365
- Publication type:
- Article
5
Predictive Science Center in Russia.
- Published in:
- Bio-IT World, 2011, v. 10, n. 5, p. 10
- By:
- Publication type:
- Article
6
Kinase inhibitors attract attention as oral rheumatoid arthritis drugs.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 257, doi. 10.1038/nrd3155
- By:
- Publication type:
- Article
7
Aromatase Inhibitors and Musculoskeletal Pain in Patients With Breast Cancer.
- Published in:
- Clinical Journal of Oncology Nursing, 2007, v. 11, n. 3, p. 433, doi. 10.1188/07.CJON.433-439
- By:
- Publication type:
- Article
8
Anastrozole (Arimidex®).
- Published in:
- Clinical Journal of Oncology Nursing, 2004, v. 8, n. 1, p. 87, doi. 10.1188/04.CJON.87-88
- By:
- Publication type:
- Article
9
AZ drug pipeline under pressure.
- Published in:
- Chemistry & Industry, 2010, n. 19, p. 6
- By:
- Publication type:
- Article
10
HRM and project intensification in R&D-based companies: a study of Volvo Car Corporation and AstraZeneca.
- Published in:
- R&D Management, 2006, v. 36, n. 5, p. 467, doi. 10.1111/j.1467-9310.2006.00448.x
- By:
- Publication type:
- Article
11
Practice Summary: Capacity Planning in the Presence of Sequence-Dependent Setups at AstraZeneca Pharmaceuticals.
- Published in:
- Interfaces, 2015, v. 45, n. 4, p. 358, doi. 10.1287/inte.2015.0801
- By:
- Publication type:
- Article
12
Editors’ declarations of interest.
- Published in:
- 2009
- Publication type:
- Editorial
13
Significant Details from the 2010 Health Care Fraud and Abuse Control Program Report.
- Published in:
- Journal of Health Care Compliance, 2011, v. 13, n. 3, p. 9
- By:
- Publication type:
- Article